Persistent Asset Partners LTD Alx Oncology Holdings Inc Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Persistent Asset Partners LTD holds 52 shares of ALXO stock, worth $58. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52Holding current value
$58% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.9 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.13 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.69 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.8 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $45.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...